Trinity Biotech (TRIB) EPS (Basic) Growth (3y) (2012 - 2024)
Trinity Biotech (TRIB) EPS (Basic) Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.52% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 7.60% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 62.89% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 60.34% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 30.65% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 29.37% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 14.53% |
| Sep 30, 2024 | -32.54% |
| Jun 30, 2024 | 7.68% |
| Mar 31, 2024 | -30.57% |
| Dec 31, 2023 | 60.86% |
| Sep 30, 2023 | -28.07% |
| Jun 30, 2023 | 23.57% |
| Mar 31, 2023 | -17.44% |
| Dec 31, 2022 | -19,190.71% |
| Sep 30, 2022 | -536.08% |
| Jun 30, 2022 | -7.63% |
| Mar 31, 2022 | -287.53% |
| Dec 31, 2021 | -11,025.30% |
| Sep 30, 2021 | -28.30% |
| Jun 30, 2021 | -32.44% |
| Mar 31, 2021 | 63.67% |
| Dec 31, 2020 | -18,548.03% |
| Sep 30, 2020 | 62.63% |
| Jun 30, 2020 | -34.35% |
| Mar 31, 2020 | -58.20% |